Myricetin is a member of the group of flavonoids called flavonols. Myricetin is obtained from various fruit, vegetables, tea, berries and red wine. Myricetin is characterized by the pysrogallol B-ring, and the more hydroxylated structure is known to be capable for its increased biological properties compared with other flavonols. Myricetin is produced by the Myricaceae, Anacardiaceae, Polygonaceae, Pinaceae and Primulacea families. It is soluble in organic solvent such as ethanol, DMSO (dimethyl sulfoxide), and dimethyl formamide (DMF). It is sparingly soluble in aqueous buffers. Myricetin shows its various pharmacological activities including antioxidant, anti-amyloidogenic, antibacterial, antiviral, antidiabetic, anticancer, anti-inflammatory, anti-epileptic and anti-ulcer. This review article focuses on pharmacological effects of Myricetin on different diseases such as osteoporotic disorder, anti-inflammatory disorder, alzheimer’s disease, anti-epileptic, cancer, cardiac disorder, diabetic metabolic disorder, hepatoprotective disorder and gastro protective disorder.

No abstract

Abstract. We present the prospect of dimuon analysis at the MINOS Near Detector. We report the selection of opposite sign charm induce dimuon events in the neutrino-nucleon deep inelastic scattering. Using a cut based optimized selection algorithm, we expect to select 1484 charm induce dimuon events in 7.0x10^'' POT of projected data. We study the cross section ratio of charm induce dimuon to single muon charge-current events in energy range 4-80 GeV in simulated events and expect a 10% statistical uncertainty on the cross section ratio in projected data. We also report the study of like sign dimuon events and compare the data with Monte Carlo prediction.

No abstract